b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="ecam" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1142193/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\xe2\x80\xb2-digallate (TF3)</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142193/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Evidence-based Complementary and Alternative Medicine" /><meta name="citation_title" content="Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\xe2\x80\xb2-digallate (TF3)" /><meta name="citation_authors" content="Chia-Nan Chen, Coney P. C. Lin, Kuo-Kuei Huang, Wei-Cheng Chen, Hsin-Pang Hsieh, Po-Huang Liang, John T.-A. Hsu" /><meta name="citation_date" content="June 2005" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="2" /><meta name="citation_firstpage" content="209" /><meta name="citation_doi" content="10.1093/ecam/neh081" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1142193/?report=abstract" /><meta name="citation_pmid" content="15937562" /><meta name="DC.Title" content="Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\xe2\x80\xb2-digallate (TF3)" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Hindawi Limited" /><meta name="DC.Contributor" content="Chia-Nan Chen" /><meta name="DC.Contributor" content="Coney P. C. Lin" /><meta name="DC.Contributor" content="Kuo-Kuei Huang" /><meta name="DC.Contributor" content="Wei-Cheng Chen" /><meta name="DC.Contributor" content="Hsin-Pang Hsieh" /><meta name="DC.Contributor" content="Po-Huang Liang" /><meta name="DC.Contributor" content="John T.-A. Hsu" /><meta name="DC.Date" content="2005 Jun" /><meta name="DC.Identifier" content="10.1093/ecam/neh081" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\xe2\x80\xb2-digallate (TF3)" /><meta property="og:type" content="article" /><meta property="og:description" content="SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL[Pro] ) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142193/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-ecam.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1142193/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1142193/pdf/neh081.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AF56DE9999421000000000831082F.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/241/">Evid Based Complement Alternat Med</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/119117/">v.2(2); 2005 Jun</a></li><li class="accid">PMC1142193</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-ecam.gif" alt="Logo of ecam" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,75" alt="Evidence-based Complementary and Alternative Medicine : eCAM" title="Evidence-based Complementary and Alternative Medicine : eCAM" href="http://www.hindawi.com/journals/ecam" ref="reftype=publisher&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Evid Based Complement Alternat Med</span>. 2005 Jun; 2(2): 209\xe2\x80\x93215. </span></div><div><span class="fm-vol-iss-date">Published online 2005 Apr 7. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1093%2Fecam%2Fneh081" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1093/ecam/neh081</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1142193</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/15937562">15937562</a></div></div></div></div><h1 class="content-title">Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3&#x02032;-digallate (TF3)</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Chen%20CN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494509738944" co-class="co-affbox">Chia-Nan Chen</a>,<sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Lin%20CP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494475177968" co-class="co-affbox">Coney P. C. Lin</a>,<sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Huang%20KK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494510303776" co-class="co-affbox">Kuo-Kuei Huang</a>,<sup>1</sup> <a href="/pubmed/?term=Chen%20WC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494439201440" co-class="co-affbox">Wei-Cheng Chen</a>,<sup>1</sup> <a href="/pubmed/?term=Hsieh%20HP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494439199168" co-class="co-affbox">Hsin-Pang Hsieh</a>,<sup>1</sup> <a href="/pubmed/?term=Liang%20PH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494509734608" co-class="co-affbox">Po-Huang Liang</a>,<sup>2</sup> and  <a href="/pubmed/?term=Hsu%20JT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562" class="affpopup" co-rid="_co_idm140494509732288" co-class="co-affbox">John T.-A. Hsu</a><sup>1,</sup><sup>3,</sup><sup>&#x02020;</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140494509738944"><h3 class="no_margin">Chia-Nan Chen</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><div>Find articles by <a href="/pubmed/?term=Chen%20CN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Chia-Nan Chen</a></div></div><div id="_co_idm140494475177968"><h3 class="no_margin">Coney P. C. Lin</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><div>Find articles by <a href="/pubmed/?term=Lin%20CP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Coney P. C. Lin</a></div></div><div id="_co_idm140494510303776"><h3 class="no_margin">Kuo-Kuei Huang</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><div>Find articles by <a href="/pubmed/?term=Huang%20KK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Kuo-Kuei Huang</a></div></div><div id="_co_idm140494439201440"><h3 class="no_margin">Wei-Cheng Chen</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><div>Find articles by <a href="/pubmed/?term=Chen%20WC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Wei-Cheng Chen</a></div></div><div id="_co_idm140494439199168"><h3 class="no_margin">Hsin-Pang Hsieh</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><div>Find articles by <a href="/pubmed/?term=Hsieh%20HP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Hsin-Pang Hsieh</a></div></div><div id="_co_idm140494509734608"><h3 class="no_margin">Po-Huang Liang</h3><p><sup>2</sup>Institute of Biological Chemistry, Academia Sinica, Taipei</p><div>Find articles by <a href="/pubmed/?term=Liang%20PH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">Po-Huang Liang</a></div></div><div id="_co_idm140494509732288"><h3 class="no_margin">John T.-A. Hsu</h3><p><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</p><p><sup>3</sup>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan</p><div>Find articles by <a href="/pubmed/?term=Hsu%20JT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15937562">John T.-A. Hsu</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140494440977568_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140494440977568_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140494440977568_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140494440977568_ai" style="display:none"><div class="fm-affl" lang="en" id="au1"><sup>1</sup>Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei</div><div class="fm-affl" lang="en" id="au2"><sup>2</sup>Institute of Biological Chemistry, Academia Sinica, Taipei</div><div class="fm-affl" lang="en" id="au3"><sup>3</sup>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan</div><div id="cor1"><sup>&#x02020;</sup>For reprints and all correspondence: John T.-A. Hsu, Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Chemistry, Academia Sinica, Taipei, Taiwan. Tel: +: 886-37-246166 ext. 35717; Fax: +886-37-586-456; E-mail: <a href="mailto:dev@null" data-email="wt.gro.irhn@ushnaust" class="oemail">wt.gro.irhn@ushnaust</a></div><div id="fn1"><sup>*</sup>These authors contributed equally to this work.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140494440977568_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2004 Sep 30; Accepted 2005 Mar 11.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140494440977568_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author (2005). Published by Oxford University Press. All rights reserved.</div><div class="license half_rhythm"><p id="__p2">The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact <a href="mailto:dev@null" data-email="gro.slanruojpuo@snoissimrep.slanruoj" class="oemail">gro.slanruojpuo@snoissimrep.slanruoj</a></p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1142193/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140494507166000" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140494507166000title">Abstract</h2><!--article-meta--><div><p id="__p3" class="p p-first-last">SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL<sup>Pro</sup>) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CL<sup>Pro</sup>. Two compounds in the library were found to be inhibitive: tannic acid (IC<sub>50</sub> = 3 &#x000b5;M) and 3-isotheaflavin-3-gallate (TF2B) (IC<sub>50</sub> = 7 &#x000b5;M). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CL<sup>Pro</sup>-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CL<sup>Pro</sup>. Several other known compositions in teas were also evaluated for their activities in inhibiting 3CL<sup>Pro</sup>. We found that caffeine, (&#x02014;)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CL<sup>Pro</sup> activity. Only theaflavin-3,3&#x02032;-digallate (TF3) was found to be a 3CL<sup>Pro</sup> inhibitor. This study has resulted in the identification of new compounds that are effective 3CL<sup>Pro</sup> inhibitors.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">natural products, 3CL<sup>Pro</sup>, black tea, TF2B, TF3</span></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">Introduction</h2><p id="__p4" class="p p-first">Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus, SARS coronavirus (SARS-CoV) (<a href="#b1" rid="b1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759193">1</a>,<a href="#b2" rid="b2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759191">2</a>). From November 1, 2002 to June 18, 2003, a total of 8465 probable SARS cases were reported to the World Health Organization from 29 countries, and 801 people died from this disease. The case&#x02013;fatality proportion was &#x0223c;10%. Although the spread of the virus has been averted, the re-emergence of SARS is still in question (<a href="#b3" rid="b3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759181">3</a>&#x02013;<a href="#b6" rid="b6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759186">6</a>).</p><p id="__p5" class="p p-last">Like other related coronaviruses, SARS-CoV is an enveloped virus containing single-stranded RNA of positive polarity. Coronaviruses have the largest genomes known (&#x0223c;30 kb) among RNA viruses [7]. The genome of SARS-CoV comprises one open reading frame (ORF) encoding two overlapping replicase polyproteins, polyprotein-1a (pp1a, &#x0223c;450 kDa) and poplyprotein-1ab (pp1ab, &#x0223c;750 kDa), responsible for virus replication (<a href="#b7" rid="b7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759194">7</a>). The rest of the genome comprises at least five ORFs encoding structural proteins and other genes with putative functions (<a href="#b8" rid="b8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759197">8</a>,<a href="#b9" rid="b9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759184">9</a>). Proteolytic processing, especially the processing of replicase polyproteins, is one of the crucial steps in the life cycle of many positive-stranded RNA viruses, including coronaviruses. All coronaviruses encode a papline-like protease (PLP) and a chymotrypsin-like (3CL<sup>Pro</sup>) protease for proteolytic procession during virus maturation (<a href="#b10" rid="b10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759188">10</a>). Studies on other coronaviruses have shown that the PLP protein cleaves at no less than two sites on the pp1a polyprotein and that the 3CL<sup>Pro</sup> protease cleaves at least 11 inter-domain sites on the pp1a and pp1ab polyproteins [7]. Thus, the 3CL<sup>Pro</sup> protease of SARS-CoV has been considered as an important molecular target for anti-SARS-CoV drug discovery and developments. In this study, after screening of a natural product library and further confirmation, we found that SARS-3CL<sup>Pro</sup> could be inhibited by compounds that are abundant in teas. We also examined crude extracts from various teas and a panel of representative natural products in teas for their inhibitory activities against SARS-3CL<sup>Pro</sup>.</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title">Methods</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">Preparation of SARS-CoV 3CL<sup>Pro</sup></h3><p id="__p6" class="p p-first-last">Total RNA extracted from a throat swab of a SARS patient was provided by the Center for Disease Control (CDC), Taipei, Taiwan. All RNA samples were handled under bio-safety level 2 (BSL2) regulations. Two primers, 5&#x02032;-GGCGGAATTCGCCTCTACCAACCACCACAGA-3&#x02032; and 5&#x02032;-GGCGGAATTCA AAGCATCCAATGATGAGTGCC-3&#x02032;, were used for reverse transcription&#x02013;polymerase chain reaction (RT&#x02013;PCR) to synthesize the cDNA of SARS-3CL<sup>Pro</sup> using Ready-to-Go RT&#x02013;PCR Beads (Amersham Biosciences, Piscataway, NJ) according to the manufacturer\'s protocol. The PCR cycle used for the amplification of cDNA of SARS-3CL<sup>Pro</sup> was as follows: 94&#x000b0;C for 5 min, 25 cycles of 94&#x000b0;C for 1 min, 58&#x000b0;C for 3 min, 72&#x000b0;C for 2 min and 72&#x000b0;C for 10 min. A full-length 3CL<sup>Pro</sup> of SARS coronavirus was successfully expressed in <em>Escherichia coli</em> as a glutathione <em>S</em>-transferase (GST) fusion protein. Following cleavage by thrombin, 3CL<sup>Pro</sup> was purified to homogeneity. A 15mer peptide with sequence H<sub>2</sub>N-SITSAVLQSGFRKMA-COOH corresponding to an autocleavage site of the SARS-3CL<sup>Pro</sup> was synthesized and used for protease cleavage activity assay. The highly purified protein was shown by high-performance liquid chromatography (HPLC) analysis to exhibit proteolytic activity <em>in trans</em>.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Compound Collection</h3><p id="__p7" class="p p-first-last">The Pure Natural Products Library used to screen for 3CL<sup>Pro</sup> inhibition was obtained from MicroSource Discovery Systems, Inc., Gaylordsville, CT. It consists of a unique collection of 720 pure natural products. The collection includes simple and complex oxygen heterocycles, alkaloids, sequiterpenes, diterpenes, pentacyclic triterpenes, sterols and many other diverse representatives. Initially, 10 different compounds were pooled, and the mixtures were tested for their inhibitory activities against SARS-3CL<sup>Pro</sup>. Positive pools were then deconvoluted and single pure compounds that were able to inhibit &#x0003e;50% of peptide cleavage at 10 &#x000b5;M were scored as hits. Other compounds were obtained from Sigma (St Louis, MO). Theaflavin (TF1), TF2 [a mixture of TF-2A (theaflavin-3-gallate) and TF-2B (theaflavin-3&#x02032;-gallate)] and theaflavin-3,3&#x02032;-digallate (TF3) were kind gifts from Dr Yu-Chih Liang, School of Medical Technology, Taipei Medical University, Taipei, Taiwan, ROC.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Preparation of Crude Extracts from Oolong Tea, Green Tea, Black Tea and Puer Tea</h3><p id="__p8" class="p p-first-last">Tea liquors were prepared from oolong tea, green tea, black tea and Puer tea (also called pu-er or pu-erh) samples as 2% (w/v) tea solutions. The water extracts of four different types of tea leaves were prepared by shaking for 10 min in boiling hot water in thermal flasks. The extracts were then filtered through a Millex-GS 0.22 &#x000b5;m filter (Millipore, Malsheim, France) to remove particulate matter. The water extracts were then evaporated under reduced pressure to obtain viscous masses. These materials were evaluated for their inhibitory activities against SARS-3CL<sup>Pro</sup>.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">Inhibition of Protease Activity of SARS-3CL<sup>Pro</sup> by HPLC Assay</h3><p id="__p9" class="p p-first-last">A general cysteine protease inhibitor, <em>N</em>-ethylmaleimide (NEM, protease inhibitor as positive control), was obtained from Sigma (St Louis, MO). This compound was tested for its inhibitory activities against SARS-3CL<sup>Pro</sup> in the peptide cleavage assay. The activities of the proteases were measured in the absence or presence of different concentrations of these general inhibitors. The enzyme (2 &#x000b5;M) was pre-incubated with chemicals for 30 min. Peptide was then added at 100 &#x000b5;M to the reaction, and mixtures were incubated at 37&#x000b0;C for 1 h. The potency of the inhibitors was calculated. The HPLC analysis condition is: a C<sub>18</sub> RP guard column (250 &#x000d7; 4.6 mm &#x000d7; 5 &#x000b5;m, Agilent Zorbax Extend). This method was chosen because it gave the best resolution among several methods that were tested. The column temperature was ambient, and the elution (0.8 ml/min) was performed using a solvent system comprising solvents A [10 MM NH<sub>4</sub>OAc, 0.1% trifluoroacetic acid (TFA)] and B (acetonitrile, 0.1% TFA) mixed using a gradient starting with 100% A, linearly decreasing to 10% A in 8 min, to 100% A in 16 min, and held at 100% A for 23 min. The injection volume was 40 ml. The UV detector was set at 214 nm.</p></div><div id="__sec7" class="sec sec-last"><h3 id="__sec7title">Proteolytic Activity of SARS-3CL<sup>Pro</sup> by Fluorogenic Substrate Peptide Assay</h3><p id="__p10" class="p p-first-last">The development of a fluorescent protease activity assay has been reported previously (<a href="#b7" rid="b7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759195">7</a>). The enhanced fluorescence due to cleavage of the fluorogenic substrate peptide (Dabcyl-KTSAVLQSGFRKME-Edans) catalyzed by the protease was monitored at 538 nm with excitation at 355 nm using a fluorescence plate reader (Fluoroskan Ascent from ThermoLabsystems, Sweden). The fluorimetric assay was used to determine the IC<sub>50</sub> of identified inhibitors on SARS 3CL<sup>Pro</sup> activity. The protease was stored in the buffer containing 12 mM Tris&#x02013;HCl (pH 7.5), 120 mM NaCl, 0.1 mM EDTA, 7.5 mM 2-mercaptoethanol and 1 mM dithiothreitol (DTT) at &#x02212;70&#x000b0;C before use.</p></div></div><div id="__sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec8title">Results</h2><div id="__sec9" class="sec sec-first"><h3 id="__sec9title">Screening of a 720 Compound Library Against 3CL<sup>Pro</sup> Activity by HPLC Assay</h3><p id="__p11" class="p p-first-last">The spectrum collection, a library of 720 drugs and natural products, was screened for 3CL<sup>Pro</sup> inhibitory activity. A flowchart of the screening procedure is shown in <a href="/pmc/articles/PMC1142193/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig. 1</span></a>. Initially, 10 different compounds were pooled, and the 72 mixtures were then tested for their inhibitory activities against SARS-3CL<sup>Pro</sup>. The HPLC assay was used in the primary screening because many compounds in the library are chromogenic. Single compounds in the positive pools were then evaluated for their activities. Two compounds, tannic acid and TF2B, were found to be active against 3CL<sup>Pro</sup> (<a href="/pmc/articles/PMC1142193/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig. 2</span></a>). Tannic acid is a water-soluble polyphenol present in plant food such as tea, red wine, beer and nuts. In addition, tea polyphenols and many tannin components are thought to be anticarcinogenic (<a href="#b14" rid="b14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759185">14</a>,<a href="#b15" rid="b15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759183">15</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC1142193/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475152416" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1142193_neh081f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is neh081f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1142193/bin/neh081f1.jpg" /></a></div><div id="largeobj_idm140494475152416" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC1142193/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><strong>Figure 1</strong></a></div><!--caption a7--><div class="caption"><p id="__p19">Flowchart of the screening of the compound library and tea compositions.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC1142193/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475149056" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1142193_neh081f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is neh081f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1142193/bin/neh081f2.jpg" /></a></div><div id="largeobj_idm140494475149056" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC1142193/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><strong>Figure 2</strong></a></div><!--caption a7--><div class="caption"><p id="__p20">Inhibition of 3CL <sup>Pro</sup> activity by HPLC assay. Injection of 40 &#x000b5;l of incubation samples for C18 reverse phase column analysis. The substrate or product fragment peaks were analyzed by HPLC with UV absorbance detection at 214 nm. The HPLC system is described in Methods.</p></div></div></div></div><div id="__sec10" class="sec"><h3 id="__sec10title">Evaluation of Tea Extracts and Pure Components from Teas for Their Inhibition of 3CL<sup>Pro</sup> Activity</h3><p id="__p12" class="p p-first-last">Since many other polyphenols related to tannic acid and TF2B are also present in various kinds of teas, we decided to examine the inhibition of activity by various tea extracts and several well known pure ingredients present in teas. Thus, water extracts from different types of teas were prepared and evaluated for their inhibitory activities against 3CL<sup>Pro</sup>. As shown in <a href="/pmc/articles/PMC1142193/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>, extracts from black and Puer teas inhibited 3CL<sup>Pro</sup> activity while those from green or oolong teas did not. We further tested the possible involvement of several known ingredients present in teas, including caffeine, theophylline, catechin (C), epigallocatechin (EGC), (&#x02014;)-epigallocatechin gallte (EGCg), epicatechin (EC), epicatechin gallate (ECg), TF1, TF2, TF2B, tannic acid and TF3. As shown in <a href="/pmc/articles/PMC1142193/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>, the results showed that methylxanthine (caffeine and theophylline) did not influence 3CL<sup>Pro</sup> activity; catechins, including C, EC, ECg, EGC and EGCg, present in green tea (unfermented) and oolong tea (partial fermented) also did not inhibit 3CL<sup>Pro</sup> activity. Our results indicated that tannic acid, TF2B and TF3 are 3CL<sup>Pro</sup> inhibitors as revealed by the fluorogenic substrate assay (<a href="/pmc/articles/PMC1142193/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig. 3</span></a>). TF2A was not tested because of its unavailability.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC1142193/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475145200" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1142193_neh081f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is neh081f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1142193/bin/neh081f3.jpg" /></a></div><div id="largeobj_idm140494475145200" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC1142193/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><strong>Figure 3</strong></a></div><!--caption a7--><div class="caption"><p id="__p21">Inhibition of 3CL<sup>Pro</sup> activity by fluorogenic substrate peptide assay. Inhibition of 3CL<sup>Pro</sup> activity by tannic acid, TF1, TF2B, TF3 and EGCg. The enhanced fluorescence due to cleavage of the fluorogenic substrate peptide catalyzed by the protease was monitored at 538 nm with exicitation at 355 nm using a fluorescence plate reader. The determining assay is described in Methods.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl1"><h3><strong>Table 1</strong></h3><!--caption a7--><div class="caption"><p id="__p23">Inhibition of SARS 3CL<sup>Pro</sup> activity by natural products</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475138320" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><tbody><tr><td align="left" colspan="1" rowspan="1">Compound library</td><td align="left" colspan="1" rowspan="1"><sup>IC</sup>50 (&#x000b5;M)</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">3-Isotheaflavin-3-gallate (TF2B)</td><td align="left" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1">Tannic acid</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Tea extract</td><td align="left" colspan="1" rowspan="1"><sup>IC</sup>50 (&#x000b5;g/ml)</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Oolong tea</td><td align="left" colspan="1" rowspan="1">125</td></tr><tr><td align="left" colspan="1" rowspan="1">Green tea</td><td align="left" colspan="1" rowspan="1">125</td></tr><tr><td align="left" colspan="1" rowspan="1">Black tea</td><td align="left" colspan="1" rowspan="1">70</td></tr><tr><td align="left" colspan="1" rowspan="1">Puer tea</td><td align="left" colspan="1" rowspan="1">25</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Other compositions in green tea</td><td align="left" colspan="1" rowspan="1"><sup>IC</sup>50 (&#x000b5;M)</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Caffeine</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Theophylline</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Catechin (C)</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Epigallocatechin (EGC)</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">(&#x02013;)-Epigallocatechin gallte (EGCg)</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Epicatechin (EC)</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">Epicatechin gallate (ECg)</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Theaflavin composition in black tea</td><td align="left" colspan="1" rowspan="1"><sup>IC</sup>50 (&#x000b5;M)</td></tr><tr><td colspan="2" align="left" rowspan="1"><hr /></td></tr><tr><td align="left" colspan="1" rowspan="1">Theaflavin (TF1)</td><td align="left" colspan="1" rowspan="1">56</td></tr><tr><td align="left" colspan="1" rowspan="1">Theaflavin-3-gallate,TF-2a and</td><td align="left" colspan="1" rowspan="1">43</td></tr><tr><td align="left" colspan="1" rowspan="1">Theaflavin-3&#x02032; -gallate,TF-2b mixture (TF2)</td><td colspan="1" rowspan="1"></td></tr><tr><td align="left" colspan="1" rowspan="1">Theaflavin-3,3&#x02032; -digallate (TF3)</td><td align="left" colspan="1" rowspan="1">9.5</td></tr></tbody></table></div><div id="largeobj_idm140494475138320" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/table/tbl1/?report=objectonly">Open in a separate window</a></div></div></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title">TF2B and TF3 as Potent Agents Against 3CL<sup>Pro</sup> Inhibitory Activity</h3><p id="__p13" class="p p-first-last">The natural product screened library consisted of simple and complex oxygen heterocycles, alkaloids, sequiterpenes, diterpenes, pentacyclic triterpenes, sterols and many other diverse representatives. Numerous black tea polyphenols (especially those of TF1, TF2 and TF3) were found to inhibit 3CL<sup>Pro</sup>. In black tea, TF3 was the most abundant (1.05%) followed by TF2A (0.34%), TF2B (0.11%) and TF1 (0.08%) (<a href="#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759180">16</a>). It is interesting to note that TF3 contained two gallate groups attached to the 3,3&#x02032; positions as shown in <a href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig. 4b</span></a>. TF2A and TF2B, on the other hand, consisted of only one gallate group attached either to the 3 or the 3&#x02032; positions, respectively (<a href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig. 4b</span></a>). In contrast, no gallate group was attached to TF1. Results in <a href="/pmc/articles/PMC1142193/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>, indicating that the gallate group attached to the 3&#x02032; position to TF2B and TF3, might be important for interaction with the 3CL<sup>Pro</sup> active site. EC, EGCg, ECG and EGC were much less active (IC<sub>50</sub> &#x02265; 100 &#x000b5;M) than theaflavins.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475142496" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1142193_neh081f4a.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is neh081f4a.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1142193/bin/neh081f4a.jpg" /></a></div><div id="largeobj_idm140494475142496" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/figure/fig4/?report=objectonly">Open in a separate window</a></div><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140494475141408" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1142193_neh081f4b.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is neh081f4b.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1142193/bin/neh081f4b.jpg" /></a></div><div id="largeobj_idm140494475141408" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1142193/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><strong>Figure 4</strong></a></div><!--caption a7--><div class="caption"><p id="__p22">Chemical structures of tannic acid, catechins and TFs.</p></div></div></div></div></div><div id="__sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec12title">Discussion</h2><p id="__p14" class="p p-first">Human coronaviruses (HCoVs) are major causes of upper respiratory tract illness in animals including humans. It has been demonstrated that a novel coronavirus causes SARS. The main protease, frequently called 3C-like protease (3CL<sup>Pro</sup>), has been identified as an attractive drug target (<a href="#b17" rid="b17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759182">17</a>). Of the 720 natural products screened in this study, tannic acid (<a href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig. 4a</span></a>) and TF2B were identified using the HPLC proteolytic assay to inhibit 50% of the proteolytic acitivity of 3CL<sup>Pro</sup> at concentrations &#x02264;10 &#x000b5;M. Both tannic acid and TF2B belong to the group of natural polyphenols found in teas. Low concentrations of tannic acid were found to inhibit proteases including tissue-type plasminogen activator, urokinase-type plasminogen activator and plasmin activity [13]. Over 300 different kinds of tea are now produced, but they are classified into three main forms: green tea is manufactured by drying fresh tea leaves, with emphasis on the prevention of oxidation of the tea polyphenols during the manufacturing process. In contrast, the manufacture of black tea is characterized by a high degree of fermentation, which produces a series of chemical condensations among the ingredients present in tea. Oolong tea is partially fermented, and the tea compositions are more similar to those found in green tea (<a href="#b18" rid="b18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759192">18</a>). In evaluating different types of tea, we found that extracts from several different types of tea, including Puer and black tea, could inhibit 3CL<sup>Pro</sup> activity while green or oolong tea could not. However, the chemical composition in Puer tea is very complex and it is difficult to isolate pure ingredients for structural identification. Purification and identification of Puer tea ingredients should be carried out in a separate study.</p><p id="__p15">We next examined whether other well-known ingredients present in tea could also inhibit 3CL<sup>Pro</sup> activity. We found that methylxanthine (caffeine and theophylline) and catechins (EGCg, EC, C, ECg and EGC) were not able to inhibit 3CL<sup>Pro</sup> activity at concentrations up to 100 &#x000b5;M (<a href="/pmc/articles/PMC1142193/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). However, TF1, TF2 and TF3 were more potent 3CL<sup>Pro</sup> inhibitors than catechins in green tea. During the fermentation step in the production of black tea, most of the catechins are oxidized and condensed into theaflavins through dimerization and into thearubigins through polymerization. Green tea contains &#x0223c;30% of catechins (dry mass base) while black tea contains &#x0223c;9% of catechins and 4% of theaflavins (<a href="#b19" rid="b19" class=" bibr popnode">19</a>). In another study, Leung <em>et al</em>. (<a href="#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759190">16</a>) reported that TF3 was the most abundant (1.05%) theaflavin in black tea followed by TF2A (0.34%), TF2B (0.11%) and TF1 (0.08%). Tannic acid is a class of polyphenolic in plants but the quantification of its levels in green or black tea is difficult because tannic acid constitutes a wide range of polymers with mol. wts of 500&#x02013;3000 Da.</p><p id="__p16">It is interesting to note that TF2B and TF3 are more potent inhibitors of 3CL<sup>Pro</sup> than TF1 (<a href="/pmc/articles/PMC1142193/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span>Table 1</span></a>). Unlike TF2B and TF3, TF1 does not contain a gallate group (<a href="/pmc/articles/PMC1142193/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig. 4b</span></a>). Thus, the addition of a gallate group attached at the 39 position to TF2B and TF3 might be important for their inhibitory activity against 3CL<sup>Pro</sup>. These results suggest that TF2B and TF3 might be good starting points for the design of more active inhibitors for the 3CL<sup>Pro</sup> encoded by SARS-CoV.</p><p id="__p17" class="p p-last">Finally, this study has identified three compounds (TF2B, TF3 and tannic acid) that are effective 3CL<sup>Pro</sup> inhibitors (IC<sub>50</sub> &#x02264;10 &#x000b5;M). These compounds are abundant in the extract of black tea (<a href="#b16" rid="b16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_98759196">16</a>,<a href="#b19" rid="b19" class=" bibr popnode">19</a>). Black tea is a popular beverage in the world. Results from this study warrant further investigation to examine the effect of these natural products in inhibition of SARS-CoV replication in cell culture. Clark <em>et al</em>. reported that theaflavins extracted from black tea were able to neutralize bovine coronavirus and rotavirus infections (<a href="#b20" rid="b20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848027935">20</a>). Thus, it will be very interesting to evaluate, in a separate study, whether drinking black tea can prevent or alleviate the infection of an enteric form of coronavirus since SARS-CoV is known to actively replicate in the intestinal tract (<a href="#b21" rid="b21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848027934">21</a>).</p></div><div id="idm140494510394144" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140494510394144title">Acknowledgments</h2><div class="sec"><p id="__p18">We thank Dr Tzong-Der Way for providing excellent technical support. This work was supported in part by funds and facilities of NHRI of Taiwan and by Grants NSC92-2751-B-400-006-Y to X.C and J.T.A.H. and NSC92-2751-B-001-012-Y to P.H.L. from the National Science Council, Taiwan.</p></div></div><div id="idm140494510393232" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140494510393232title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1">1. <span class="citation">Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al.  A novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1953\xe2\x80\x9366.</span> [<a href="/pubmed/12690092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&amp;author=TG+Ksiazek&amp;author=D+Erdman&amp;author=CS+Goldsmith&amp;author=SR+Zaki&amp;author=T+Peret&amp;volume=348&amp;publication_year=2003&amp;pages=1953-66&amp;pmid=12690092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2">2. <span class="citation">Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1967\xe2\x80\x9376.</span> [<a href="/pubmed/12690091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Identification+of+a+novel+coronavirus+in+patients+with+severe+acute+respiratory+syndrome&amp;author=C+Drosten&amp;author=S+Gunther&amp;author=W+Preiser&amp;author=S+van+der+Werf&amp;author=HR+Brodt&amp;volume=348&amp;publication_year=2003&amp;pages=1967-76&amp;pmid=12690091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3">3. <span class="citation">Enserink M. Infectious diseases: calling all coronavirologists. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:413\xe2\x80\x934.</span> [<a href="/pubmed/12702853" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Infectious+diseases:+calling+all+coronavirologists&amp;author=M+Enserink&amp;volume=300&amp;publication_year=2003&amp;pages=413-4&amp;pmid=12702853&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4">4. <span class="citation">Enserink M, Vogel G. Infectious diseases: hungry for details, scientists zoom in on SARS genomes. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:715\xe2\x80\x937.</span> [<a href="/pubmed/12730563" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Infectious+diseases:+hungry+for+details,+scientists+zoom+in+on+SARS+genomes&amp;author=M+Enserink&amp;author=G+Vogel&amp;volume=300&amp;publication_year=2003&amp;pages=715-7&amp;pmid=12730563&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5">5. <span class="citation">Wenzel RP, Edmond MB. Managing SARS amidst uncertainty. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1947\xe2\x80\x938.</span> [<a href="/pubmed/12748313" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Managing+SARS+amidst+uncertainty&amp;author=RP+Wenzel&amp;author=MB+Edmond&amp;volume=348&amp;publication_year=2003&amp;pages=1947-8&amp;pmid=12748313&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6">6. <span class="citation">Holmes KV, Enjuanes L. Virology: the SARS coronavirus: a postgenomic era. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1377\xe2\x80\x938.</span> [<a href="/pubmed/12775826" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Virology:+the+SARS+coronavirus:+a+postgenomic+era&amp;author=KV+Holmes&amp;author=L+Enjuanes&amp;volume=300&amp;publication_year=2003&amp;pages=1377-8&amp;pmid=12775826&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7">7. <span class="citation">Hegyi A, Friebe A, Gorbalenya AE, Ziebuhr J. Mutational analysis of the active centre of coronavirus 3C-like proteases. <span><span class="ref-journal">J Gen Virol. </span>2002;<span class="ref-vol">83</span>:581\xe2\x80\x9393.</span> [<a href="/pubmed/11842253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Mutational+analysis+of+the+active+centre+of+coronavirus+3C-like+proteases&amp;author=A+Hegyi&amp;author=A+Friebe&amp;author=AE+Gorbalenya&amp;author=J+Ziebuhr&amp;volume=83&amp;publication_year=2002&amp;pages=581-93&amp;pmid=11842253&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8">8. <span class="citation">Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, et al.  The genome sequence of the SARS-associated coronavirus. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1399\xe2\x80\x93404.</span> [<a href="/pubmed/12730501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+genome+sequence+of+the+SARS-associated+coronavirus&amp;author=MA+Marra&amp;author=SJ+Jones&amp;author=CR+Astell&amp;author=RA+Holt&amp;author=A+Brooks-Wilson&amp;volume=300&amp;publication_year=2003&amp;pages=1399-404&amp;pmid=12730501&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9">9. <span class="citation">Rota PA, Oberste MS, Monroe SS, Nix WA. Campagnoli R, Icenogle JP et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1394\xe2\x80\x939.</span> [<a href="/pubmed/12730500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Campagnoli+R,+Icenogle+JP+et+al.+Characterization+of+a+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&amp;author=PA+Rota&amp;author=MS+Oberste&amp;author=SS+Monroe&amp;author=WA+Nix&amp;volume=300&amp;publication_year=2003&amp;pages=1394-9&amp;pmid=12730500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10">10. <span class="citation">Herold J, Gorbalenya AE, Thiel V, Schelle B, Siddell SG. Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate. <span><span class="ref-journal">J Virol. </span>1998;<span class="ref-vol">72</span>:910\xe2\x80\x938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC124560/">PMC free article</a>]</span> [<a href="/pubmed/9444982" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Proteolytic+processing+at+the+amino+terminus+of+human+coronavirus+229E+gene+1-encoded+polyproteins:+identification+of+a+papain-like+proteinase+and+its+substrate&amp;author=J+Herold&amp;author=AE+Gorbalenya&amp;author=V+Thiel&amp;author=B+Schelle&amp;author=SG+Siddell&amp;volume=72&amp;publication_year=1998&amp;pages=910-8&amp;pmid=9444982&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11">11. <span class="citation">Ziebuhr J, Thiel V, Gorbalenya AE. The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:33220\xe2\x80\x932.</span> [<a href="/pubmed/11431476" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+autocatalytic+release+of+a+putative+RNA+virus+transcription+factor+from+its+polyprotein+precursor+involves+two+paralogous+papain-like+proteases+that+cleave+the+same+peptide+bond&amp;author=J+Ziebuhr&amp;author=V+Thiel&amp;author=AE+Gorbalenya&amp;volume=276&amp;publication_year=2001&amp;pages=33220-2&amp;pmid=11431476&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12">12. <span class="citation">Ziebuhr J, Siddell SG. Processing of the human coronavirus 229E replicase polyproteins by the virus-encoded 3C-like proteinase: identification of proteolytic products and cleavage sites common to pp1a and pp1ab. <span><span class="ref-journal">J Virol. </span>1999;<span class="ref-vol">73</span>:177\xe2\x80\x9385.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC103821/">PMC free article</a>]</span> [<a href="/pubmed/9847320" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Processing+of+the+human+coronavirus+229E+replicase+polyproteins+by+the+virus-encoded+3C-like+proteinase:+identification+of+proteolytic+products+and+cleavage+sites+common+to+pp1a+and+pp1ab&amp;author=J+Ziebuhr&amp;author=SG+Siddell&amp;volume=73&amp;publication_year=1999&amp;pages=177-85&amp;pmid=9847320&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13">13. <span class="citation">Taitzoglou IA, Tsantarliotou M, Zervos I, Kouretas D, Kokolis NA. Inhibition of human and ovine acrosomal enzymes by tannic acid <em>in vitro</em>. <span><span class="ref-journal">Reproduction. </span>2001;<span class="ref-vol">121</span>:131\xe2\x80\x937.</span> [<a href="/pubmed/11226036" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Reproduction&amp;title=Inhibition+of+human+and+ovine+acrosomal+enzymes+by+tannic+acid+in+vitro&amp;author=IA+Taitzoglou&amp;author=M+Tsantarliotou&amp;author=I+Zervos&amp;author=D+Kouretas&amp;author=NA+Kokolis&amp;volume=121&amp;publication_year=2001&amp;pages=131-7&amp;pmid=11226036&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14">14. <span class="citation">Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:8118\xe2\x80\x9321.</span> [<a href="/pubmed/14678963" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Cancer+prevention+by+tea+polyphenols+is+linked+to+their+direct+inhibition+of+antiapoptotic+Bcl-2-family+proteins&amp;author=M+Leone&amp;author=D+Zhai&amp;author=S+Sareth&amp;author=S+Kitada&amp;author=JC+Reed&amp;volume=63&amp;publication_year=2003&amp;pages=8118-21&amp;pmid=14678963&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15">15. <span class="citation">Kazi A, Urbizu DA, Kuhn DJ, Acebo AL, Jackson ER, Greenfelder GP, et al.  A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells. <span><span class="ref-journal">Int J Mol Med. </span>2003;<span class="ref-vol">12</span>:879\xe2\x80\x9387.</span> [<a href="/pubmed/14612961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Med&amp;title=A+natural+musaceas+plant+extract+inhibits+proteasome+activity+and+induces+apoptosis+selectively+in+human+tumor+and+transformed,+but+not+normal+and+non-transformed,+cells&amp;author=A+Kazi&amp;author=DA+Urbizu&amp;author=DJ+Kuhn&amp;author=AL+Acebo&amp;author=ER+Jackson&amp;volume=12&amp;publication_year=2003&amp;pages=879-87&amp;pmid=14612961&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16">16. <span class="citation">Leung LK, Su Y, Chen R, Zhang Z, Huang Y, Chen ZY. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. <span><span class="ref-journal">J Nutr. </span>2001;<span class="ref-vol">131</span>:2248\xe2\x80\x9351.</span> [<a href="/pubmed/11533262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Nutr&amp;title=Theaflavins+in+black+tea+and+catechins+in+green+tea+are+equally+effective+antioxidants&amp;author=LK+Leung&amp;author=Y+Su&amp;author=R+Chen&amp;author=Z+Zhang&amp;author=Y+Huang&amp;volume=131&amp;publication_year=2001&amp;pages=2248-51&amp;pmid=11533262&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17">17. <span class="citation">Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1763\xe2\x80\x937.</span> [<a href="/pubmed/12746549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Coronavirus+main+proteinase+(3CLpro)+structure:+basis+for+design+of+anti-SARS+drugs&amp;author=K+Anand&amp;author=J+Ziebuhr&amp;author=P+Wadhwani&amp;author=JR+Mesters&amp;author=R+Hilgenfeld&amp;volume=300&amp;publication_year=2003&amp;pages=1763-7&amp;pmid=12746549&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18">18. <span class="citation">Chen CN, Liang CM, Lai JR, Tsai YJ, Tsay JS, Lin JK. Capillary electrophoretic determination of theanine, caffeine, and catechins in fresh tea leaves and oolong tea and their effects on rat neurosphere adhesion and migration. <span><span class="ref-journal">J Agric Food Chem. </span>2003;<span class="ref-vol">51</span>:7495\xe2\x80\x93503.</span> [<a href="/pubmed/14640605" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Agric+Food+Chem&amp;title=Capillary+electrophoretic+determination+of+theanine,+caffeine,+and+catechins+in+fresh+tea+leaves+and+oolong+tea+and+their+effects+on+rat+neurosphere+adhesion+and+migration&amp;author=CN+Chen&amp;author=CM+Liang&amp;author=JR+Lai&amp;author=YJ+Tsai&amp;author=JS+Tsay&amp;volume=51&amp;publication_year=2003&amp;pages=7495-503&amp;pmid=14640605&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19">19. <span class="citation">Harbowy ME, Balentine DA. Tea chemistry. <span><span class="ref-journal">Crit Rev Plant Sci. </span>1997;<span class="ref-vol">16</span>:415\xe2\x80\x9380.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Rev+Plant+Sci&amp;title=Tea+chemistry&amp;author=ME+Harbowy&amp;author=DA+Balentine&amp;volume=16&amp;publication_year=1997&amp;pages=415-80&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20">20. <span class="citation">Clark KJ, Grant PG, Sarr AB, Belakere JR, Swaggerty CL, Phillips TD, et al.  An <em>in vitro</em> study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections. <span><span class="ref-journal">Vet Microbiol. </span>1998;<span class="ref-vol">63</span>:147\xe2\x80\x9357.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7117136/">PMC free article</a>]</span> [<a href="/pubmed/9850995" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vet+Microbiol&amp;title=An+in+vitro+study+of+theaflavins+extracted+from+black+tea+to+neutralize+bovine+rotavirus+and+bovine+coronavirus+infections&amp;author=KJ+Clark&amp;author=PG+Grant&amp;author=AB+Sarr&amp;author=JR+Belakere&amp;author=CL+Swaggerty&amp;volume=63&amp;publication_year=1998&amp;pages=147-57&amp;pmid=9850995&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21">21. <span class="citation">Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, Yuen KY, Sung JJ. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. <span><span class="ref-journal">Gastroenterology. </span>2003;<span class="ref-vol">125</span>:1011\xe2\x80\x937.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7126982/">PMC free article</a>]</span> [<a href="/pubmed/14517783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterology&amp;title=Enteric+involvement+of+severe+acute+respiratory+syndrome-associated+coronavirus+infection&amp;author=WK+Leung&amp;author=KF+To&amp;author=PK+Chan&amp;author=HL+Chan&amp;author=AK+Wu&amp;volume=125&amp;publication_year=2003&amp;pages=1011-7&amp;pmid=14517783&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1142193&amp;issue-id=119117&amp;journal-id=241&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Evidence-based Complementary and Alternative Medicine : eCAM</span> are provided here courtesy of <strong>Hindawi Limited</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1142193/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1142193/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1142193/pdf/neh081.pdf">PDF (129K)</a></li> | <li><a href="#" data-citationid="PMC1142193" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1142193%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1142193%2F&amp;text=Inhibition%20of%20SARS-CoV%203C-like%20Protease%20Activity%20by%20Theaflavin-3%2C3%E2%80%B2-digallate%20(TF3)"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1142193%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="15937562" data-aiid="1142193" data-aid="1142193" data-iid="119117" data-domainid="241" data-domain="ecam" data-accid="PMC1142193" data-md5="1326abcd40e786ee59afc5fe99678b05"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:07:20-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AF56DE9999421000000000831082F&amp;ncbi_session=8A1AF56DE99AA071_2097SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1142193%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=ecam&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1142193/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AF56DE99AA071_2097SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'